New President & CEO at Arbutus Bio | ABUS Message Board Posts

Arbutus Biopharma

  ABUS website

ABUS   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  34638 of 34746  at  6/17/2019 9:27:15 AM  by

Southerncross1


 In response to msg 34637 by  Steve_382
view thread

Re: New President & CEO at Arbutus Bio

 Viiv healthcare (where Mr. Collier served as president):  76.5% of the company is now owned by GlaxoSmithKline, 13.5% by Pfizer and 10% by Shionogi.  Has a significant market share of the HIV market. 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 2     Views: 226
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
34639 Re: New President & CEO at Arbutus Bio The Rooster 0 6/17/2019 10:30:22 AM






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...